Angiotensin IV Activates the Nuclear Transcription Factor-κB and Related Proinflammatory Genes in Vascular Smooth Muscle Cells
- 13 May 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 96 (9) , 965-973
Abstract
Inflammation is a key event in the development of atherosclerosis. Nuclear factor-κB (NF-κB) is important in the inflammatory response regulation. The effector peptide of the renin angiotensin system Angiotensin II (Ang II) activates NF-κB and upregulates some related proinflammatory genes. Our aim was to investigate whether other angiotensin-related peptides, as the N-terminal degradation peptide Ang IV, could regulate proinflammatory factors (activation of NF-κB and related genes) in cultured vascular smooth muscle cells (VSMCs). In these cells, Ang IV increased NF-κB DNA binding activity, caused nuclear translocation of p50/p65 subunits, cytosolic IκB degradation and induced NF-κB–dependent gene transcription. Ang II activates NF-κB via AT 1 and AT 2 receptors, but AT 1 or AT 2 antagonists did not inhibit NF-κB activation caused by Ang IV. In VSMC from AT 1a receptor knockout mice, Ang IV also activated NF-κB pathway. In those cells, the AT 4 antagonist divalinal diminished dose-dependently Ang IV–induced NF-κB activation and prevented IκB degradation, but had no effect on the Ang II response, indicating that Ang IV activates the NF-κB pathway via AT 4 receptors. Ang IV also increased the expression of proinflammatory factors under NF-κB control, such as MCP-1, IL-6, TNF-α, ICAM-1, and PAI-1, which were blocked by the AT 4 antagonist. Our results reveal that Ang IV, via AT 4 receptors, activates NF-κB pathway and increases proinflammatory genes. These data indicate that Ang IV possesses proinflammatory properties, suggesting that this Ang degradation peptide could participate in the pathogenesis of cardiovascular diseases.Keywords
This publication has 40 references indexed in Scilit:
- Angiotensin II, via AT1 and AT2 Receptors and NF-κB Pathway, Regulates the Inflammatory Response in Unilateral Ureteral ObstructionJournal of the American Society of Nephrology, 2004
- Evidence That the Angiotensin IV (AT4) Receptor Is the Enzyme Insulin-regulated AminopeptidaseJournal of Biological Chemistry, 2001
- Contractile effects of angiotensin peptides in rat aorta are differentially dependent on tyrosine kinase activityJournal of the Renin-Angiotensin-Aldosterone System, 2001
- Preactivated monocytes from hypertensive patients as a factor for atherosclerosis?Atherosclerosis, 2001
- Transcription factor-κB (NF-κB) and renal diseaseKidney International, 2001
- Angiotensin III increases MCP-1 and activates NF-кB and AP-1 in cultured mesangial and mononuclear cellsKidney International, 2000
- Tumor Necrosis Factor-α-inducible IκBα Proteolysis Mediated by Cytosolic m-CalpainJournal of Biological Chemistry, 1999
- Angiotensin IV inhibits neurite outgrowth in cultured embryonic chicken sympathetic neuronesBrain Research, 1996
- Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV.Journal of Clinical Investigation, 1995
- The Angiotensin IV System: Functional ImplicationsFrontiers in Neuroendocrinology, 1995